Home  |  About the Book  |  Table of Contents  |  Search  |  Archive  |  Order  |  Visit JCO  |  Visit ASCO.org
ASCO Educational Book; 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar content in this book
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remick, S. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Remick, S. C.

Responding to the Global Cancer Burden through Partnerships

Scot C. Remick, MD

From the Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

Supported in part by NIH grant nos. CA121947.

Address reprint requests to Scot C. Remick, MD, Mary Babb Randolph Cancer Center, 1801 Health Sciences South, PO Box 9300, Morgantown, WV 26506; email: sremick{at}hsc.wvu.edu

Overview: Cancer is no longer a disease of the industrialized world or resource-rich nations. It is becoming a worldwide public-health problem. Recent global mortality data reveal that more persons died from cancer than from AIDS, tuberculosis, or malaria combined. It is projected that by 2010, cancer will be the single greatest cause of mortality, and by 2030, there will be 27 million new cancer cases worldwide. Clearly, efforts and programs to build cancer care-capacity must be identified in order to provide new opportunities to address the global cancer burden and health inequalities in resource-constrained regions of the world. Numerous organizations and agencies are paving ways forward to improve strategies for prevention, early diagnosis, treatment, and palliative care for the patient with cancer. Pragmatic approaches are needed that are mutually rewarding, bidirectional, and entail highly interactive and collaborative partnerships. These successful strategies will be paramount to address the global cancer burden.